Adverse drug reactions are one of the leading causes of death in the US. While healthcare costs and medication-related mistakes rise, pharmacogenomics—a field of research that studies how an individual’s genes affect how he or she responds to specific medications—is becoming more accessible. Coriell Life Sciences, a precision medicine company, uses genetic science and research to improve lives, reduce healthcare costs, and speed the time to clinical decisions with its tool, GeneDose LIVE powered by Amazon Web Services (AWS). The Fix This team chatted with Scott Megill, president and chief executive officer at Coriell Life Sciences. Scott explains how GenDose LIVE impacts healthcare providers and patients.